Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page
- Check2 days agoChange DetectedThe page’s displayed application/release revision updated from v3.5.2 to v3.5.3, indicating a minor site software/version update rather than a change to the study record itself.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedThe history log now shows an addition of Revision v3.5.0 and a deletion of Revision v3.4.2.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Study Status and Recruitment Status entries, including Terminated and Sponsor decision dated 2026-02-23 and 2026-02-20. The previous 'Active, not recruiting' status from 2024-08-01 was removed.SummaryDifference0.8%

- Check73 days agoChange DetectedAdded revision v3.4.2 to the record history and removed v3.4.1. These are minor maintenance changes that do not affect study data or user-facing content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history shows a new revision entry v3.4.1 and removal of v3.4.0, indicating a minor update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.